Drugs / anti-siglec-6 CAR-T cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05488132 | Apr 2022 → Mar 2024 | acute myeloid leukemia | Xuzhou Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-siglec-6 CAR-T cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05488132 ↗ |
| Modality | Cell therapy | “autologous CAR-T cells” NCT05488132 ↗ |